Aerogen

Galway, Ireland Founded: 1997 • Age: 29 yrs Acquired By Nektar
Vibrating mesh nebulizers are manufactured for aerosol drug delivery.

About Aerogen

Aerogen is a company based in Galway (Ireland) founded in 1997 by John Power was acquired by Nektar in August 2005.. Aerogen has raised $18 million across 4 funding rounds from investors including J P Morgan, Temasek and European Union. Aerogen offers products and services including Aerogen Solo and Aerogen Ultra.

  • Headquarter Galway, Ireland
  • Founders John Power
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Aerogen Medical Devices India Private Limited
  • Date of Incorporation 17 Dec, 2019
  • Jurisdiction New Delhi, Delhi, India
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
    $868.76 K (USD)
    1252.22
    as on Mar 31, 2022
  • Net Profit
    $-261.95 K (USD)
    -285.32
    as on Mar 31, 2022
  • EBITDA
    $-282.14 K (USD)
    -71.7
    as on Mar 31, 2022
  • Total Equity Funding
    $18 M (USD)

    in 4 rounds

  • Latest Funding Round
    $94.83 K (USD), Grant

    Jun 01, 2022

  • Investors
    J P Morgan

    & 7 more

  • Employee Count
    Employee Count
  • Acquired by
    Nektar

    (Aug 15, 2005)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Aerogen

Aerogen offers a comprehensive portfolio of products and services, including Aerogen Solo and Aerogen Ultra. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Aerogen Solo is employed as a single-patient-use device that facilitates aerosol drug delivery across stages of respiratory therapy, including invasive and non-invasive ventilation.

Aerogen Ultra is utilized as a handheld device in conjunction with other products to support inhalation treatments during respiratory exacerbations or post-ventilation scenarios.

People of Aerogen
Headcount 50-200
Employee Profiles 6
Board Members and Advisors 4
Employee Profiles
People
John Power
Founder & CEO
People
Alaa Asi
Commercial Sales Director , MEA Region
People
Lorna Nolan
Global Talent Acquisition Lead
People
Dave Mescal
Head Of People & Organisational Development

Unlock access to complete

Board Members and Advisors
people
Bernard Collins
Chairman
people
Jane E. Shaw
Board Member
people
John O'Dea
Board Member
people
Ethan Park
Board Member

Unlock access to complete

Funding Insights of Aerogen

Aerogen has successfully raised a total of $18M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $94.83 thousand completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 4
  • Last Round Grant — $94,827
  • First Round

    (17 Sep 1998)

  • Investors Count 7
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2022 Amount Grant - Aerogen Valuation

investors

Jan, 2020 Amount Grant - Aerogen Valuation

investors

Jan, 2019 Amount Post-IPO - Aerogen Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Aerogen

Aerogen has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include J P Morgan, Temasek and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
VC firm that focuses on early stage investments in the US
Founded Year Domain Location
Early-stage investing in IT and healthcare ventures.
Founded Year Domain Location
Tech-based companies are invested in by Wheatley Partners.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Aerogen

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Aerogen

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Aerogen Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Aerogen

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Aerogen

Frequently Asked Questions about Aerogen

When was Aerogen founded?

Aerogen was founded in 1997 and raised its 1st funding round 1 year after it was founded.

Where is Aerogen located?

Aerogen is headquartered in Galway, Ireland.

Who is the current CEO of Aerogen?

John Power is the current CEO of Aerogen. They have also founded this company.

Is Aerogen a funded company?

Aerogen is a funded company, having raised a total of $18M across 4 funding rounds to date. The company's 1st funding round was a Post-IPO of $11.46M, raised on Sep 17, 1998.

What is the annual revenue of Aerogen?

Annual revenue of Aerogen is $868.76K as on Mar 31, 2022.

What does Aerogen do?

Aerogen was established in 1997 in Galway, Ireland, within the medical devices sector. Vibrating mesh nebulizers are produced for aerosol drug delivery in respiratory therapy applications. These devices support invasive and non-invasive mechanical ventilation, high-flow systems, and self-ventilating methods. Single-patient-use options, handheld units, controllers, and accessories are offered for compatibility with various respiratory equipment.

What products or services does Aerogen offer?

Aerogen offers Aerogen Solo and Aerogen Ultra.

Who are Aerogen's investors?

Aerogen has 8 investors. Key investors include J P Morgan, Temasek, European Union, Invesco Mutual Fund, and Nektar.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available